PRECISION BIOSCIENCES INC — Director's Dealing 2024

Jun 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2024-06-07

Reporting Person: SMITH J. JEFFERSON (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-07	Common Stock	M	163	—	Acquired	68609	Direct
2024-06-10	Common Stock	S	50	$11.79	Disposed	68559	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-07	Restricted Stock Units	$	M	163	Disposed		Common Stock (163)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7931	Indirect

Footnotes

F1: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $12.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.

F5: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024.